Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression
Phyllis F. Cheung(German Cancer Research Center), Jens T. Siveke(German Cancer Research Center)
Cited by 92
Related Papers
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
|Nature Medicine|2015|414
Characterization of a dual <scp>BET</scp>/<scp>HDAC</scp> inhibitor for treatment of pancreatic ductal adenocarcinoma
|International Journal of Cancer|2020|52
Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line
|Cancer Cell International|2016|22